Table 5.
Mean BCVA in visit windowsa
| Total analysis population (n = 573) | ||
|---|---|---|
| Visit windowb | Mean logMAR (SD) | Mean approximate ETDRS letters (SD) |
| Baseline (n = 539) | 0.673 (0.387) | 51.4 (19.3) |
| Week 6 (n = 418) | 0.493 (0.378) | 60.3 (18.9) |
| Week 12 (n = 365) | 0.522 (0.414) | 58.9 (20.7) |
| Week 24 (n = 297) | 0.551 (0.426) | 57.5 (21.3) |
| Week 36 (n = 81) | 0.550 (0.457) | 57.5 (22.8) |
| Week 48 (n = 24) | 0.538 (0.447) | 58.1 (22.3) |
BCVA best-corrected visual acuity, ETDRS Early Treatment Diabetic Retinopathy Study, SD standard deviation
a Mean values shown represent the mean for all patients with Snellen visual acuity data within the visit window. Patients with visual acuity measurements based on finger count or hand motion were excluded from the analysis
b Visit windows were baseline: day 1; week 6: days 2–63; week 12: days 64–126; and week 24: days 127–210. Additional visit windows for patients who had data collected beyond the 6 months called for in the study protocol were week 36: days 211–294 and week 48: day 295–last day in study